Partell Specialty Pharmacy Recalls Testosterone/Anastrozole Pellets Due to Sterility Concerns
Partell Specialty Pharmacy is recalling Testosterone/Anastrozole pellets because they were sterilized using a non-approved method.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the risk of infection associated with non-sterile injectable drugs.
Plain-English summary
Partell Specialty Pharmacy is recalling Testosterone/Anastrozole 120 mg/8 mg pellets packaged in amber vials. The recall is due to the use of a non-approved method of sterilization, which raises concerns about the sterility of the drug products.
The affected products are prescription-only and were distributed only in Nevada. The recall covers specific lots identified by the codes 20171220@11 and 20180201@33.
Consumers with these products should stop using them and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Testosterone/Anastrozole 120 mg/8 mg pellets packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
- Manufacturer
- Partell Specialty Pharmacy
- Category
- Drug — Injectable Pellets
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot#: 20171220@11
- BUD 06/18/2018
- 20180201@33
- BUD 07/31/2018.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 49 recalled by Partell Specialty Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Partell Specialty Pharmacy
See all →- SeverePartell Specialty Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- HighPartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFDA Recalls Testosterone/Anastrozole Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereTestosterone and Anastrazole Pellets Recalled for Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Testosterone and Anastrazole Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereQualgen Testosterone and Anastrozole Pellets Recalled for Sterility Concerns
FDA (Drugs) · 2018-11-14
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- HighTestosterone and anastrozole pellets recalled over potential metal particulate
FDA (Drugs) · 2026-02-18